GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer (Phase Ib/Ⅱ)

NCT07738341 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer (Locally Advanced or Metastatic)

Interventions

DRUG: GB268
DRUG: Nab-Paclitaxel
DRUG: Datopotamab Deruxtecan (Dato-DXd)
DRUG: Sacituzumab Tirumotecan

Sponsor

Eddingpharm (Zhuhai) Co., Ltd.